OrACORe Director Comments on Safety of Steroid Joint Injections

  • October 17, 2019

A recent study published in Radiology raised concerns about the potential long-term effects of corticosteroid injections on joint degradation when used as treatment for knee osteoarthritis. OrACORe Director Jeffrey N. Katz, MD, MSc, commented on the study and its implications for clinical care in a recent WBUR article. As quoted in the story, Katz said, "So for clinicians and patients…

Research Assistants Reunite at Perelman School of Medicine

  • September 6, 2019

Angela Chen and Genny Silva parted ways as OrACORe research assistants in June only to be reunited two months later as medical school classmates. (Photo courtesy of Chen.) After two years as colleagues at OrACORe, former research assistants Angela Chen and Genny Silva are now classmates at the University of Pennsylvania's Perelman School of Medicine. On August 16, just two…

NEWS FEATURE ON METEOR TRIAL

  • July 11, 2019

The New York Times included the MeTeOR Trial in a list of 10 notable studies that provide evidence contradicting common medical practices.

NEWS FEATURE ON ANALYSIS OF DATA FROM THE MeTeOR TRIAL

  • April 26, 2019

An analysis of data from the MeTeOR Trial published this month in Arthritis Care & Research examined the progression of osteoarthritis disease severity on MRI images among patients whose meniscal tears were treated with physical therapy or arthroscopic partial meniscectomy.

Webinar on Physical Activity and Knee OA

  • January 8, 2019

Dr. Losina's recent webinar, hosted by the Osteoarthritis Action Alliance, is available to view online. Dr. Losina discusses the measurement of physical activity (PA) in those with knee osteoarthritis, as well as the implications of the relatively low levels of PA in this population. Click here to access the webinar.

News Feature on OAPol Analysis of Coaching + Financial Incentives

  • August 22, 2018

Click here to read a news feature on a recent OAPol analysis using data from the SPARKS trial. We found that health coaching plus financial incentives may be a cost-effective treatment compared to usual care in total knee replacement recipients.

Dr. Katz Honored with Pillar Mentoring Award

  • August 21, 2018

This year, Dr. Katz was selected to receive the Brigham and Women's Physicians Organization Pillar Award for outstanding senior faculty mentor. Dr. Katz was selected based upon his contributions; the support of mentees, peers, and colleagues; and the nomination of Division Chief Dr. James Kang. The Pillar Awards, established in 2013, recognize achievements in five categories viewed as pillars of…

OrACORe & PIVOT in the News

  • March 20, 2018

NIH Medline Plus discusses the results of the SPARKS trial.   Brigham Health's Vital Lines recently featured an OAPol model study examining the lower utilization rates of total knee replacement among racial and ethnic minorities.

Month in Review-January & February 2018

  • March 6, 2018

Publications Losina E, Usiskin IM, Smith SR, Sullivan JK, Smith KC, Hunter DJ, Messier SP, Paltiel AD, Katz JN. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: A model-based evaluation. Osteoarthritis Cartilage. 2018 Feb 23. PMID: 29481917. Collins JE. What can our hands tell us about the future of our knees? Arthritis Rheumatol. 2018 Feb 22. PMID: 29471592. Losina E, Katz JN. Hydroxychloroquine: another battle lost in…

Reuters Health News Features OAPol Analysis

  • February 23, 2018

An OAPol analysis published last month in Arthritis Care & Research examined the loss of quality-adjusted life years among racial minorities due to disparities in total knee replacement utilization. Click here for coverage by Reuters Health.